Breaking News

PL BioScience Announces Major Site Expansion

The new 1,200 square-meter facility in Germany expands headquarters to support growth and scale Human Platelet Lysate production.

By: Rachel Klemovitch

Assistant Editor

PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, announced a significant expansion of its company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, animal-free cell culture supplements. The facility will serve as a hub for research and product innovation, supporting the development of next-generation HPL-based media, such as artificial HPL. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters